FAQ
PLT – Pharma License Trade is an international pharmaceutical marketplace operated by PSE. The platform is designed to connect pharmaceutical companies and highlight potential collaboration opportunities.
No, PLT is not a standalone search platform in the traditional sense.
Since pharmaceutical licensing deals and collaboration projects are often complex and regulatory requirements must be taken into account, PSE oversees every step of the process. The website therefore serves primarily as a marketplace and initial source of information for available offers and potential collaborations.
Pharmaceutical offers that PSE has received and reviewed in advance may be published on the PLT website.
In particular, offers are published for which the necessary contractual framework between the provider and PSE has been defined. This is intended to ensure that only reputable and transparent offers appear on the website.
PLT is aimed at companies and service providers in the pharmaceutical sector.
These include, for example, marketing authorization holders, manufacturers, suppliers, primary and secondary packagers, batch controllers, distributors, as well as companies seeking or offering pharmaceutical licensing rights, GMP dossiers, or collaborations.
After registration, PSE verifies whether the company belongs to an authorized user group.
PLT can be used to map out various pharmaceutical collaboration opportunities, for example:
- Purchase or sale of GMP dossiers
- Search for licensing partners
- Offers or requests for co-distribution rights
- Search for manufacturing partners
- Search for interim manufacturing partners
- Search for primary or secondary packagers
- Search for batch control partners
- Search for distribution partners
- Search for integrated pharmaceutical partners for multiple process steps
The process typically begins with an inquiry or registration. PSE then reviews the company and its proposal.
If an offer or request is generally suitable, PSE assists with further evaluation and facilitates potential contact between the companies involved. Depending on the project, additional technical, regulatory, or organizational steps may be required.
Yes. PSE reviews offers and requests before they are published or forwarded to potential partners.
The goal is to consider only legitimate offers and well-founded inquiries. In addition, the process is designed to ensure that quality assurance is transparent and documentable.
Yes, the initial contact will be made confidentially through PSE.
This can be particularly useful if a company does not yet wish to go public at the outset, or if the goal is to first assess whether a potential partner is a good fit.
The costs depend on the specific project and the scope of support requested.
PSE will be happy to provide a customized quote upon request.
Buyers do not pay a brokerage fee.
Yes, PSE can continue to provide support even after the initial contact.
This includes, for example, regulatory issues, change notifications, drug approvals, market access, market analyses, or other preparatory steps for potential commercialization.
PSE provides more resources in addition to the PLT database. These include, in particular, the numerous analytical tools available at www.pse-analytics.de.
This allows users not only to manage license offers and requests, but also to incorporate key market information into their strategic decisions.